Noonan syndrome, Lancet, vol.381, pp.333-375, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00562941
, J Paediatr Child Health, vol.50, pp.14-20, 2014.
Noonan syndrome: clinical features, diagnosis, and management guidelines, Pediatrics, vol.126, pp.746-59, 2010. ,
Clinical and molecular studies in a large Dutch family with Noonan syndrome, Am J Med Genet, vol.53, pp.187-91, 1994. ,
Genetic and pathogenetic aspects of Noonan syndrome and related disorders, Horm Res, vol.72, pp.57-63, 2009. ,
The face of Noonan syndrome: does phenotype predict genotype, Am J Med Genet A, vol.152, pp.1960-1966, 2010. ,
, Am Fam Physician, vol.89, pp.37-43, 2014.
Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/ MAPK pathway, Horm Res, vol.71, pp.185-93, 2009. ,
Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome, J Hum Genet, vol.53, pp.834-875, 2008. ,
Noonan syndrome: clinical aspects and molecular pathogenesis, Mol Syndromol, vol.1, pp.2-26, 2010. ,
Patients with Noonan Syndrome phenotype : spectrum of clinical features and congenital heart defect, Rwanda Medical Journal, vol.68, pp.26-31, 2010. ,
Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/ MEK/ERK pathway, Pediatr Int, vol.52, pp.557-62, 2010. ,
Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction, Hum Mol Genet, vol.15, pp.220-226, 2006. ,
The RASopathies: developmental syndromes of Ras/ MAPK pathway dysregulation, Curr Opin Genet Dev, vol.19, pp.230-236, 2009. ,
PTPN11 mutations in Noonan syndrome: molecular spectrum, genotypephenotype correlation, and phenotypic heterogeneity, Am J Hum Genet, vol.70, pp.1555-63, 2002. ,
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease, Am J Hum Genet, vol.78, pp.279-90, 2006. ,
The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders, Hum Mutat, vol.29, pp.992-1006, 2008. ,
Noonan syndrome and clinically related disorders, Best Pract Res Clin Endocrinol Metab, vol.25, pp.161-79, 2011. ,
Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues, Am J Med Genet Part A, vol.167, pp.1-10, 2015. ,
Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKK? gene deletion, Hum Mutat, vol.21, pp.8-11, 2003. ,
Incontinentia pigmenti: report on data from 2000 to 2013, Orphanet J Rare Dis, vol.9, p.93, 2014. ,
Incontinentia pigmenti in a boy with Klinefelter's syndrome, J Med Genet, vol.24, pp.439-480, 1987. ,
Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-?B activation, Hum Mol Genet, vol.13, pp.1763-73, 2004. ,
Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease, Hum Mutat, vol.35, pp.165-77, 2014. ,
DOI : 10.1002/humu.22483
Incontinentia pigmenti diagnostic criteria update, Clin Genet, vol.85, pp.536-578, 2014. ,
, Nucleic Acids Res, vol.38, issue.16, 2010.
UMD-predictor: a high-throughput sequencing compliant system for pathogenicity prediction of any human cDNA substitution, Hum Mutat, vol.37, pp.439-485, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01670164
Improved molecular diagnosis of the common recurrent intragenic deletion mutation in IKBKG in a Filipino family with incontinentia pigmenti, Aust J Dermatol, vol.57, pp.150-153, 2016. ,
Prenatal diagnosis of hypoplastic left heart syndrome associated with Noonan syndrome and de novo RAF1 mutation, Prenat Diagn, vol.32, pp.1016-1024, 2012. ,
PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome, J Hum Genet, vol.53, pp.999-1006, 2008. ,
Germline gain-of-function mutations in RAF1 cause Noonan syndrome, Nat Genet, vol.39, pp.1013-1020, 2007. ,
Two cases of LEOPARD syndrome-RAF1 mutations firstly described in children, Turk J Pediatr, vol.53, pp.687-91, 2011. ,
The RAF proteins take Centre stage, Nat Rev Mol Cell Biol, vol.5, pp.875-85, 2004. ,
Identification of a novel de novo deletion in RAF1 associated with biventricular hypertrophy in Noonan syndrome, Am J Med Genet Part A, vol.164, pp.2069-73, 2014. ,
Noonan's syndrome associated with hypoplastic left heart, Cardiology, vol.77, pp.62-67, 1990. ,
Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation, Hum Mutat, vol.31, pp.284-94, 2010. ,
Gainof-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy, Nat Genet, vol.39, p.1007, 2007. ,
A novel mutation on RAF1 in association with fetal findings suggestive of Noonan syndrome, Fetal Pediatr Pathol, vol.34, pp.361-365, 2015. ,
MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1 L613V mutation, Differences, vol.121, pp.1009-1034, 2011. ,
Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms, Ann N Y Acad Sci, vol.1214, pp.99-121, 2010. ,
Syndrome of the month, J Med Genet, vol.31, p.744, 1994. ,
Unique cerebrovascular anomalies in Noonan syndrome with RAF1 mutation, J Child Neurol, vol.29, pp.1-6, 2013. ,
A boy with Burkitt lymphoma associated with Noonan syndrome due to a mutation in RAF1, Am J Med Genet A, vol.161, pp.1401-1405, 2013. ,
Cardiomyopathies in Noonan syndrome and the other RASopathies, Prog Pediatr Cardiol, vol.39, pp.13-22, 2015. ,
A tunisian patient with two rare syndromes: triple a syndrome and congenital hypogonadotropic hypogonadism, Horm Res Paediatr, vol.82, pp.338-381, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01375104
Comorbidity in the Tunisian population, Clin Genet, vol.89, pp.312-321, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01374974